Overview:
Retatrutide is a next-generation peptide currently in clinical trials, designed as a triple incretin receptor agonist — targeting GLP-1, GIP, and glucagon receptors simultaneously. Early results suggest it may surpass even tirzepatide in weight loss and metabolic improvements, with potential applications in obesity, diabetes, and fatty liver disease.
Primary Benefits:
Significant weight loss (average >24% in early trials)
Improves blood sugar control and insulin sensitivity
Enhances fat metabolism via glucagon receptor activity
May improve cardiovascular and liver health markers
Potentially more powerful than semaglutide and tirzepatide
Notes:
Still in clinical trials; not yet FDA-approved
Administered via subcutaneous injection
Being studied for obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD/NASH)
GLP-1 Retatrutide
Research-Only Disclaimer: THIS PRODUCT IS FOR RESEARCH USE ONLY. IT IS NOT INTENDED FOR HUMAN CONSUMPTION, DIAGNOSTIC, THERAPEUTIC, OR VETERINARY USE. BY PURCHASING THIS PRODUCT, YOU AGREE THAT IT WILL BE USED SOLELY FOR LEGITIMATE SCIENTIFIC OR LABORATORY RESEARCH PURPOSES.
This product has not been approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other regulatory authority. It is sold solely for research purposes.
No Medical Claims
No claims are made regarding the efficacy, safety, or effectiveness of this product for any medical purpose. Any information provided is for research discussion only.
The Buyer assumes all risk associated with the use, handling, storage, and disposal of this product. The Buyer is responsible for compliance with all applicable local, state, national, and international laws and regulations.
Limitation of LiabilityTo the maximum extent permitted by law, The Vital Collective and its suppliers disclaim all warranties, expressed or implied, including, but not limited to, the implied warranties of merchantability and fitness for a particular purpose. In no event shall The Vital Collective be liable for any indirect, incidental, special, consequential, or exemplary damages (including but not limited to loss of data, revenue, or profits) arising from the use or inability to use the product, even if The Vital Collective has been advised of the possibility of such damages.
No Advice Provided
Information provided on this website is for general informational and research purposes only and is not a substitute for professional scientific, medical, or legal advice.